Hedge Fund - CR Intrinsic Investors

Sac Subsidiary Bio, Returns, AUM, Net Worth

CR Intrinsic Investors is one of SAC Capital's subsidiaries, and one of its foci is on the biopharmaceutical industry. CR Intrinsic has previously employed Mathew Martoma, a portfolio manager who was charged with insider trading by the SEC earlier this year. CR Intrinsic's $600 million settlement was the largest of its kind on record. The fund has an estimated $2 billion to $3 billion in assets under management.

Sac Subsidiary
Fund Profile
Filing Period:
Fund Name: CR Intrinsic Investors
Manager Sac Subsidiary
Portfolio Value $0
Change This QTR 0.00%
Fund Holdings Sector Distribution
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value (x$1000) Activity % Port
1. JCI 0 $0 0%
2. KAR 0 $0 0%
3. KS 0 $0 0%
4. GMCR 0 $0 0%
5. KEX 0 $0 0%
News, Interviews and Investor Letters